The pharmacological protection of the ischaemic heart: the use of calcium and beta-adrenoceptor antagonists.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003327:Coronary Disease / Q000188:drug therapy*; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D008929:Mitochondria, Heart / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009543:Nifedipine / Q000494:pharmacology; D010096:Oxprenolol / Q000494:pharmacology; D010477:Perfusion; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D014700:Verapamil / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D010096:Oxprenolol; D000255:Adenosine Triphosphate; D011433:Propranolol; D014700:Verapamil; D009543:Nifedipine